Charles Schwab’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Charles Schwab’s Portfolio MDVL Stock Details MDVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-238	Closed	-$2.91K	–	3661
2023 Q2	$2.91K	Hold	238	–	–	﹤0.01%	3608
2023 Q1	$3.4K	Hold	238	–	–	﹤0.01%	3549
2022 Q4	$3.56K	Hold	238	–	–	﹤0.01%	3546
2022 Q3	$10K	Hold	238	–	–	﹤0.01%	3508
2022 Q2	$19K	Sell	238 -259	-52%	-$22.7K	﹤0.01%	3524
2022 Q1	$25K	Hold	497	–	–	﹤0.01%	3572
2021 Q4	$35K	Hold	497	–	–	﹤0.01%	3539
2021 Q3	$73K	Hold	497	–	–	﹤0.01%	3412
2021 Q2	$305K	Buy	+497	New	+$324K	﹤0.01%	3239

Other funds holding MDVL

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Cigna Investments Bloomfield, Connecticut $773M AUM 44.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab's MDVL Position: Q3 2023 in Review

Charles Schwab sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q3 2023, closing a stake of 238 shares — an estimated $2.91K sold.

Charles Schwab first reported a position in MDVL in Q2 2021 and held it in 9 quarters. The position peaked at $305K in Q2 2021. 19 funds tracked by Wall St. Rank hold MDVL as of Q3 2023.

Charles Schwab reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Charles Schwab sold 238 MedAvail Holdings, Inc. Common Stock shares in Q3 2023, an estimated $2.91K.
Charles Schwab first reported a position in MedAvail Holdings, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
Charles Schwab's MedAvail Holdings, Inc. Common Stock position peaked at $305K in Q2 2021.
19 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q3 2023.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.